{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-120852","form_type":"8-K","ticker":"COR","cik":"0001140859","company_name":"Cencora, Inc.","filed_at":"2025-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.880546+00:00","generated_at":"2026-05-16T13:09:45.560653+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cencora acquires OneOncology majority stake for $3.6B, retires $1.3B debt; total cash ~$5.0B","bullets":["Enterprise value $7.4B; Cencora paying $3.6B for majority equity and retiring $1.3B OneOncology debt.","Acquisition expected to close by end of fiscal Q2 2026, subject to regulatory approvals.","Cencora paused share repurchases; FY2026 adjusted EPS guidance reiterated but likely lower half of $17.45-$17.75.","Long-term guidance raised: adjusted operating income growth 7-10%, adjusted EPS growth 10-14%.","Financing via new debt; $4.5B bridge financing committed; committed to investment grade ratings."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-120852","json":"https://secwatch.observer/filing/0001104659-25-120852.json","markdown":"https://secwatch.observer/filing/0001104659-25-120852.md","text":"https://secwatch.observer/filing/0001104659-25-120852.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1140859/000110465925120852/0001104659-25-120852-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1140859/000110465925120852/tm2533461d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:09:45.560653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}